The Latest Breaking News from FDA

The recently approved contraception Opill should be available for consumers next year. It's not clear how or whether insurance will cover it. Here's what's known so far.

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

As the U.S. struggles with prescription drug shortages, South Dakota Gov. Kristi Noem has advanced a modest plan that she hopes will prod Washington to address weaknesses in the international pharmaceutical supply chain

The World Health Organization's cancer research arm deemed aspartame as possibly carcinogenic to humans, but the Food and Drug Administration doesn't agree.

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

While it is not a cure, proof that drugs can alter course of disease is regarded as significant triumph

"The room is half full of libertarians and half full of very liberal Democrats. The bridge is food"

The potential of ashwagandha is promising, but the side effects remain a mystery

Katie Rosseinsky’s consumption is not on the level of Donald Trump’s, but she’s still concerned about its possible links to cancer. She explores the history of diet drinks, why more women drink them, and whether she should stop